UiPath Inc. (NYSE:PATH) Shares Sold by Strs Ohio

Strs Ohio lessened its holdings in UiPath Inc. (NYSE:PATHFree Report) by 32.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,071 shares of the healthcare company’s stock after selling 14,893 shares during the quarter. Strs Ohio’s holdings in UiPath were worth $771,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in UiPath in the fourth quarter worth $223,000. Lecap Asset Management Ltd. acquired a new position in shares of UiPath during the fourth quarter valued at $1,661,000. Simplicity Solutions LLC boosted its holdings in shares of UiPath by 4.9% during the fourth quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after acquiring an additional 598 shares during the period. Friedenthal Financial acquired a new position in shares of UiPath during the fourth quarter valued at $743,000. Finally, Tennessee Valley Asset Management Partners acquired a new position in shares of UiPath during the fourth quarter valued at $50,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Trading Up 0.7 %

Shares of UiPath stock opened at $19.69 on Thursday. The company’s 50-day moving average price is $22.42 and its two-hundred day moving average price is $21.55. UiPath Inc. has a 52 week low of $12.38 and a 52 week high of $27.87. The stock has a market cap of $11.20 billion, a PE ratio of -115.82 and a beta of 0.96.

UiPath (NYSE:PATHGet Free Report) last issued its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. The firm had revenue of $405.25 million for the quarter, compared to analysts’ expectations of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. On average, equities analysts predict that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insiders Place Their Bets

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the business’s stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $21.66, for a total transaction of $866,400.00. Following the sale, the chief financial officer now owns 660,762 shares in the company, valued at approximately $14,312,104.92. The transaction was disclosed in a filing with the SEC, which is available through this link. In the last quarter, insiders have sold 72,000 shares of company stock worth $1,591,360. Company insiders own 31.03% of the company’s stock.

Wall Street Analysts Forecast Growth

PATH has been the subject of several analyst reports. TD Cowen boosted their price target on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, March 14th. Scotiabank boosted their price target on shares of UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a report on Thursday, March 14th. KeyCorp initiated coverage on shares of UiPath in a report on Monday, April 8th. They set an “overweight” rating and a $27.00 price target for the company. Canaccord Genuity Group lifted their price objective on shares of UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Finally, Morgan Stanley lifted their price objective on shares of UiPath from $17.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, March 14th. Nine analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, UiPath has a consensus rating of “Moderate Buy” and a consensus price target of $27.41.

View Our Latest Research Report on UiPath

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATHFree Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.